乳腺癌幸存者的治疗总结和护理计划:可接受性和可行性研究
Maria das Graças Silva Matsubara1, Fabiana Baroni Alves Makdissi1, Simone Elias2
1AC Camargo Cancer Center, São Paulo, SP, Brazil.
Revista latino-americana de enfermagem
|July 30, 2025
概括
乳腺癌幸存者的治疗总结和护理计划 (TSSCP-P Br) 文件是可行的,并且可以接受临床实践. 这个工具支持乳腺癌幸存者和医疗保健专业人员在随访护理中.
科学领域:
- 在瘤学瘤学.
- 护理 护理 护理
- 医疗保健服务研究 医疗服务研究
背景情况:
- 乳腺癌幸存者需要有效的工具来持续管理护理.
- 乳腺癌幸存者的治疗摘要和护理计划 (TSSCP-P Br) 是为了帮助这一过程而开发的.
研究的目的:
- 评估TSSCP-P Br文件的可行性和可接受性.
- 从乳腺癌幸存者和医疗保健专业人员的角度评估其实用性.
主要方法:
- 这是一项涉及50名乳腺癌幸存者和10名护士的横截式混合方法研究.
- 通过可行性和可接受性问卷和内容分析收集数据.
- 使用描述性统计数据分析的定量数据.
主要成果:
- 幸存者报告了高度保留 (98.0%) 和遵守 (99.3%) 文件.
- 在适合性,方便性,有效性和坚持性方面,幸存者的接受率达到了81.6%.
- 医疗保健专业人员将可行性和可接受性评为84.2%,并指出专业经验是关键因素.
结论:
- TSSCP-P Br文档是临床实践中可行的和可接受的工具.
- 它展示了提高乳腺癌幸存者的护理潜力.
- 建议进一步纳入常规后续护理.
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Nursing Evaluation
3.6K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.6K
Comparing the Survival Analysis of Two or More Groups
289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Kaplan-Meier Approach
270
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
270


